» Articles » PMID: 31236626

Functions of 'A Disintegrin and Metalloproteases (ADAMs)' in the Mammalian Nervous System

Overview
Publisher Springer
Specialty Biology
Date 2019 Jun 26
PMID 31236626
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

'A disintegrin and metalloproteases' (ADAMs) are a family of transmembrane proteins with diverse functions in multicellular organisms. About half of the ADAMs are active metalloproteases and cleave numerous cell surface proteins, including growth factors, receptors, cytokines and cell adhesion proteins. The other ADAMs have no catalytic activity and function as adhesion proteins or receptors. Some ADAMs are ubiquitously expressed, others are expressed tissue specifically. This review highlights functions of ADAMs in the mammalian nervous system, including their links to diseases. The non-proteolytic ADAM11, ADAM22 and ADAM23 have key functions in neural development, myelination and synaptic transmission and are linked to epilepsy. Among the proteolytic ADAMs, ADAM10 is the best characterized one due to its substrates Notch and amyloid precursor protein, where cleavage is required for nervous system development or linked to Alzheimer's disease (AD), respectively. Recent work demonstrates that ADAM10 has additional substrates and functions in the nervous system and its substrate selectivity may be regulated by tetraspanins. New roles for other proteolytic ADAMs in the nervous system are also emerging. For example, ADAM8 and ADAM17 are involved in neuroinflammation. ADAM17 additionally regulates neurite outgrowth and myelination and its activity is controlled by iRhoms. ADAM19 and ADAM21 function in regenerative processes upon neuronal injury. Several ADAMs, including ADAM9, ADAM10, ADAM15 and ADAM30, are potential drug targets for AD. Taken together, this review summarizes recent progress concerning substrates and functions of ADAMs in the nervous system and their use as drug targets for neurological and psychiatric diseases.

Citing Articles

Serum proteomic correlates of mental health symptoms in a representative UK population sample.

Dearman A, Bao Y, Schalkwyk L, Kumari M Brain Behav Immun Health. 2025; 44:100947.

PMID: 39911945 PMC: 11795072. DOI: 10.1016/j.bbih.2025.100947.


Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer's disease.

Ao J, Picard C, Auld D, Zetterberg H, Brinkmalm A, Blennow K Mol Psychiatry. 2025; .

PMID: 39827219 DOI: 10.1038/s41380-024-02884-z.


Single-nucleus multi-omics analyses reveal cellular and molecular innovations in the anterior cingulate cortex during primate evolution.

Yuan J, Dong K, Wu H, Zeng X, Liu X, Liu Y Cell Genom. 2024; 4(12):100703.

PMID: 39631404 PMC: 11701334. DOI: 10.1016/j.xgen.2024.100703.


Microglia-derived ADAM9 promote GHRH neurons pyroptosis by Mad2L2-JNK-caspase-1 pathway in subarachnoid hemorrhage.

Mao J, Bao Y, Liu F, Ye Q, Peng J, Nie J J Neuroinflammation. 2024; 21(1):302.

PMID: 39563331 PMC: 11575213. DOI: 10.1186/s12974-024-03299-x.


Deciphering the oncogenic potential of ADAM9 in hepatocellular carcinoma through bioinformatics and experimental approaches.

Jiang L, Huang W, Cao M, Jiang Y, Li S, Li M Sci Rep. 2024; 14(1):26432.

PMID: 39488509 PMC: 11531474. DOI: 10.1038/s41598-024-74650-8.


References
1.
Hinkle C, Diestel S, Lieberman J, Maness P . Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM). J Neurobiol. 2006; 66(12):1378-95. DOI: 10.1002/neu.20257. View

2.
Jackson L, Qiu T, Sunnarborg S, Chang A, Zhang C, Patterson C . Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 2003; 22(11):2704-16. PMC: 156761. DOI: 10.1093/emboj/cdg264. View

3.
Bartsch J, Wildeboer D, Koller G, Naus S, Rittger A, Moss M . Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection. J Neurosci. 2010; 30(36):12210-8. PMC: 6633558. DOI: 10.1523/JNEUROSCI.1520-10.2010. View

4.
Endres K, Fahrenholz F . Regulation of α-secretase ADAM10 expression and activity. Exp Brain Res. 2011; 217(3-4):343-52. DOI: 10.1007/s00221-011-2885-7. View

5.
Lourenco M, Clarke J, Frozza R, Bomfim T, Forny-Germano L, Batista A . TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys. Cell Metab. 2013; 18(6):831-43. DOI: 10.1016/j.cmet.2013.11.002. View